Remifentanil in the intensive care unit: tolerance and acute withdrawal syndrome after prolonged sedation.
Delvaux
Bernard
B
Anesthesiology Department, University Hospital Saint-Luc, Catholic University of Louvain, Avenue Hippocrate 10, B-1200 Brussels, Belgium. delvauxbernard@yahoo.fr
Ryckwaert
Yves
Y
Van Boven
Michel
M
De Kock
Marc
M
Capdevila
Xavier
X
D000328:Adult; D000368:Aged; D016292:Procedural Sedation / Q000009:adverse effects / Q000379:methods; D004361:Drug Tolerance / Q000502:physiology; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects*; D007362:Intensive Care Units; D008297:Male; D010880:Piperidines / Q000009:adverse effects*; D000077208:Remifentanil; D013375:Substance Withdrawal Syndrome / Q000175:diagnosis*; D013997:Time Factors
D006993:Hypnotics and Sedatives; D010880:Piperidines; D000077208:Remifentanil